NHS England Offers ‘Improved’ Orkambi Deal, But Vertex Lukewarm
Executive Summary
The NHS in England says it has made a “revised and improved” offer to Vertex to make Orkambi available, but the company is not impressed and says its attitude to the negotiations has been mischaracterized.
You may also be interested in...
Vertex Trikafta Approved As First Triple Combo For Cystic Fibrosis With $311,503 Price Tag
The US FDA cleared the combination in just three months for patients with the most common genetic mutation. Company sets price above double regimen Symdeko, but in line with trailblazer Kalydeco.
UK Buyers Club Aims For Lower-Cost Cystic Fibrosis Drugs
A buyers club in the UK is planning to import generic versions of Vertex’s cystic fibrosis drugs that are not available on the NHS. Some commentators think such clubs may become more common.
UK Buyers Club To Get Lower Cost Versions Of Vertex’s CF Drugs
A buyers club in the UK is planning to import generic versions of Vertex’s cystic fibrosis drugs that are not available on the NHS. Some commentators think such clubs may become more common.